Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer

Completed · Phase 3 · Has a placebo group

Conditions studied: Breast Cancer, Colorectal Cancer

In brief

RATIONALE: Shark cartilage extract may help shrink or slow the growth of colorectal cancer or breast cancer cells. PURPOSE: Randomized phase III trial to determine the effectiveness of shark cartilage in treating patients who have advanced colorectal cancer or advanced breast cancer.

Key facts

Study ID: NCT00026117
Run by: Alliance for Clinical Trials in Oncology
People needed: 88
Starts: 2001-08-01
Expected to finish: 2006-09-01
Last updated by the study team: 2016-07-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

CCOP - Scottsdale Oncology Program — Scottsdale, Arizona, United States
Mayo Clinic — Jacksonville, Florida, United States
CCOP - Illinois Oncology Research Association — Peoria, Illinois, United States
CCOP - Carle Cancer Center — Urbana, Illinois, United States
CCOP - Cedar Rapids Oncology Project — Cedar Rapids, Iowa, United States
CCOP - Iowa Oncology Research Association — Des Moines, Iowa, United States
Siouxland Hematology-Oncology — Sioux City, Iowa, United States
CCOP - Wichita — Wichita, Kansas, United States
CCOP - Duluth — Duluth, Minnesota, United States
CentraCare Health Plaza — Saint Cloud, Minnesota, United States
CCOP - Missouri Valley Cancer Consortium — Omaha, Nebraska, United States
Medcenter One Health System — Bismarck, North Dakota, United States
CCOP - Merit Care Hospital — Fargo, North Dakota, United States
CCOP - Toledo Community Hospital — Toledo, Ohio, United States
Rapid City Regional Hospital — Rapid City, South Dakota, United States
CCOP - Sioux Community Cancer Consortium — Sioux Falls, South Dakota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.